eRegister's captcha

Patent Register Details

Print page icon Print this page

PATENT REGISTER
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2019/010
Status Granted Patent No. 2727918
Application No. 14152945.3 Date of Filing 27/08/2010
Date Grant Published 12/10/2016 Application Published 07/05/2014
Title of Invention Compounds and Compositions as Protein Kinase Inhibitors
Priority
Priority Country Filing Date Application No.
 United States of America  28/08/2009  238073 P
 United States of America  11/03/2010  313039 P
Inventors Huang, Shenlin
Jin, Xianming
Liu, Zuosheng
Poon, Daniel
Tellew, John
Wan, Yongqin
Wang, Xing
Xie, Yongping
Current Proprietor Array Biopharma Inc.
3200 Walnut Street
Boulder, CO 80301
UNITED STATES OF AMERICA
Address for service F.F. GORMAN & CO.
15 Clanwilliam Square
Dublin 2
IRELAND
Renewal Fees
Year Date Renewed
 14  26/07/2023
 13  26/07/2022
 12  26/07/2021
 11  27/07/2020
 10  27/08/2019
 9  27/08/2018
 8  30/08/2017
Earlier Application No. 10748211.9 Granted
Publication Language English
Translation Received Date
17/11/2016 Divisional Application number: 16193400.5 Date of receipt: 11/10/2016
09/01/2017 Address for Service recorded as F.F. GORMAN & CO., 15 Clanwilliam Square, Dublin 2, Ireland received on 30/12/2016.
08/06/2018 By virtue of a Licence dated 03/12/2015 PIERRE FABRE MEDICAMENT, 45 Place Abel Gance, 92100 Boulogne-Billancourt, France, have been registered as exclusive licensee and is limited to the component "Encorafenib".
01/03/2019 Request for grant a Supplementary Protection Certificate, citing Patent number 2727918 as the relevant basic patent, in respect of the product Combination of binimetinib and encorafenib, each in all forms protected by the basic patent filed on 20/02/2019. Reference number of request is 2019/010.
28/01/2021 Request for grant of Supplementary Protection Certification No. 2019/010 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009